According to Geiga, supplementation back to adequate levels can help improve vascular health and lower blood pressure.

Rami Katkhuda, an analyst from LifeSci Capital, maintained the Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report). The ...

Mineralys Therapeutics, Inc. (MLYS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.

The company is primarily focused on developing treatments for hypertension and chronic kidney diseases. Its clinical-stage ...

Completed enrollment in pivotal Advance-HTN trial and anticipate topline data in March 2025 – – Completed enrollment ahead of schedule in pivotal Phase 3 Launch-HTN trial and anticipate delivering ...

Low testosterone in women and people assigned female at birth could cause sluggishness, muscle weakness, irregular periods, ...

For patients with primary hyperaldosteronism, AVS is sometimes essential in identifying whether excess aldosterone production originates from one or both adrenal glands. This precision allows doctors ...